Laparoscopic cholecystectomy: 5-mm versus 3-mm ports

ISRCTN ISRCTN33058794
DOI https://doi.org/10.1186/ISRCTN33058794
Secondary identifying numbers lapchole3mm
Submission date
30/09/2009
Registration date
21/07/2010
Last edited
19/09/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Mr Mark Bignell
Scientific

c/o Mr Rhodes Secretary
Department of General Surgery
Norfolk and Norwich Hospital
Colney Lane
Norwich
NR4 7UY
United Kingdom

Study information

Study designInterventional single centre double blind randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA prospective, randomised, double-blind trial comparing 5-mm versus 3-mm ports for laparoscopic cholecystectomy
Study hypothesisThe principal research question is to see if there is any benefit in terms of post-operative pain and cosmetic outcome following laparoscopic cholecystectomy when the ports are reduced in size from 5-mm to 3-mm whilst evaluating the 5-mm technique for patient satisfaction.
Ethics approval(s)Submitted to Cambridgeshire 4 Research Ethics Committee (REC) on the 5th October 2009, review taking place on the 22nd October 2009 (ref: 09/H0305/96)
ConditionSymptomatic gallstone disease including pancreatitis
InterventionPatients will be randomised to the standard '5-mm' laparoscopic cholecystectomy or the '3-mm' laparoscopic cholecystectomy. The difference between the two being the epigastric and right upper quadrant ports. The umbilical port is 10-mm in size in both cases.
Intervention typeOther
Primary outcome measure1. Post-operative pain, measured with the Visual Analogue Scale at 6 hours, 1 week and 6 months post-operatively
2. Scar cosmesis, assessed at 6 months using a validated scar questionnaire - Patient Scar Assessment Questionnaire
Secondary outcome measures1. Operating time, measured in minutes and starting from the time the surgeon is ready to make the first incision until the time the dressings have been applied
2. Conversion to the other technique will apply in the 3-mm group only and the use of any 5-mm port to aid removal of the gallbladder will be classed as a conversion to the standard technique. Any conversions to open will also be recorded
3. Histology of the gallbladders, assessed from the formal histology reports and will be divided into acute cholecystitis, chronic cholecystitis, and normal gallbladder wall
4. Gallbladder wall thickness
5. Operative complications, measured immediately, and late complications will be assessed at 1 week and at 6-month follow up appointments
Overall study start date01/12/2009
Overall study end date01/12/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit70 Years
SexBoth
Target number of participants100
Participant inclusion criteria1. Symptomatic gallstone disease
2. Age 18 to 70 years, either sex
3. Suitable for day-case procedure
Participant exclusion criteria1. Acute cholecystitis or empyema of gallbladder
2. Not fit for day-case procedure
Recruitment start date01/12/2009
Recruitment end date01/12/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

c/o Mr Rhodes Secretary
Norwich
NR4 7UY
United Kingdom

Sponsor information

Norfolk and Norwich University Hospitals NHS Foundation Trust (UK)
Hospital/treatment centre

c/o Kath Andrews
Research and Development Office
Level 3 East Block, Colney Lane
Norwich
NR4 7UY
England
United Kingdom

Website http://www.nnuh.nhs.uk/
ROR logo "ROR" https://ror.org/01wspv808

Funders

Funder type

Other

Karl Storz (UK) - providing equipment

No information available

All other costs will be covered by NHS under usual treatment costs.

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2013 Yes No